Weight loss technology for people with treated type 2 diabetes: a randomized controlled trial

Simple item page
dc.contributor.authorOshakbayev, Kuat
dc.contributor.authorDukenbayeva, Bibazhar
dc.contributor.authorTogizbayeva, Gulnar
dc.contributor.authorDurmanova, Aigul
dc.contributor.authorGazaliyeva, Meruyert
dc.contributor.authorSabir, Abdul
dc.contributor.authorIssa, Aliya
dc.contributor.authorIdrisov, Alisher
dc.date.accessioned2017-11-22T06:16:39Z
dc.date.available2017-11-22T06:16:39Z
dc.date.issued2017
dc.description.abstractBackground: The prevalence of type 2 diabetes is increasing in worldwide despite the development of new treatment methods. Aim of the study was to evaluate a weight loss method on body composition, glycemic, lipid and hormone profiles, blood pressure and reactive oxygen species in people with treated type 2 diabetes. Methods: A 24-week open, prospective, randomized, controlled clinical trial including 272 adult patients with treated type 2 diabetes was performed. The patients were divided in two groups: Main group consisted of 208 patients who followed a method including a calorie restriction diet and optimal physical activity; Control included 64 patients who received conventional drug treatment with weight loss. Main Outcome Measures were weight loss, fasting glucose and 2-hour oral glucose tolerance test (OGTT), HbA1c. Secondary endpoints were blood pressure, lipid and insulin blood levels. Results: At 24 weeks, patients in Main weight lost between 8-18 kg (10–21%); their body mass index significantly decreased (-4.2 kg/m2) as well as their waist circumference (-13 cm) compared to Control. In Main weight loss was achieved fatty mass reduction. In Main fasting glucose and OGTT, HbA1c, blood pressure, reactive oxygen species decreased significantly, whereas hemoglobin levels and heel bone mineral density increased. In Main blood insulin levels decreased by 72.0%, cortisol levels decreased by 40.7%, while testosterone levels in men increased by 2.4 times from baseline. The application of the weight loss method led to a decrease in drug doses leading to their complete withdrawal. Conclusions: The results of this study show the beneficial role of a weight loss method in improving glycemic, lipid and hormone profiles, electrolyte and biochemical indices, blood pressure, reactive oxygen species and bone mineral density in patients with treated type 2 diabetes.ru_RU
dc.identifier.citationOshakbayev Kuat et al.(>7), 2017, Weight loss technology for people with treated type 2 diabetes: a randomized controlled trial, Nutrition & Metabolismru_RU
dc.identifier.uriDOI 10.1186/s12986-017-0163-9
dc.identifier.urihttp://nur.nu.edu.kz/handle/123456789/2842
dc.language.isoenru_RU
dc.publisherNutrition & Metabolismru_RU
dc.rightsOpen Access - the content is available to the general publicru_RU
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/us/*
dc.subjecttype 2 diabetesru_RU
dc.subjectweight lossru_RU
dc.subjectrestriction dietru_RU
dc.subjectglycemic/lipid and hormone profilesru_RU
dc.subjectlipid/protein oxidationru_RU
dc.titleWeight loss technology for people with treated type 2 diabetes: a randomized controlled trialru_RU
dc.typeArticleru_RU

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Weight loss technology.pdf
Size:
1.34 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
6 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

UMC_Articles